Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Search
About Us
Sign in
Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Products
WEEKLY
FOCUS
ALPHA
Project Updates and Milestones news
(page 15)
29 April 2026
Exolum to develop Avonmouth CO2 storage hub with Severnside Carbon
New Avonmouth CO2 storage and shipping terminal will open by 2031, handling up to 6Mt/yr via rail and ship to serve southwest England, Midlands and South Wales and enable CCUS access.
29 April 2026
ROSI raises €20m+ to scale PV recycling in Europe
€20M+ plus EU grants to fund industrial expansion: 10,000 t/yr solar-panel recycling plant in Spain, scalable automated line, new production director appointed, recycling partnership renewed
29 April 2026
AkzoNobel adds Iris CMX drone for precise aircraft coating inspections
Aerofleet adds a contact-sensor drone to pair with its visual-scan drone, capturing thickness, color and gloss. Dual-drone inspections take ~30 min, improving repaint timing and cutting costs.
29 April 2026
BASF Coatings switches European production to renewable electricity
Completed Europe-wide switch to renewable power, complementing low-CO2 supply in France. Measure cuts Scope-2 emissions, supports 40% per-ton CO2 reduction by 2030 and improves product footprints.
29 April 2026
UPM Q1 2026: Strong start led by decarbonization solutions
Q1 sales €2,505m; comparable EBIT €274m (-5%); operating cash flow €89m; net debt €2,962m. Energy and biofuels strong. H1 comparable EBIT guidance €325–525m.
29 April 2026
TotalEnergies completes 50% acquisition of EPH flexible power portfolio in Europe
Creates TTEP: 14 GW flexible gas/biomass + BESS across Italy, UK, Ireland, Netherlands, France; ~30 TWh output in 2025; tolling contracts; 5 GW development pipeline.
The right choices in the European chemical industry
Save time with
chemXplore Alpha
Learn more
29 April 2026
Symrise Q1 2026: Organic sales -0.4%, full-year outlook reaffirmed
Strength in Food & Beverage, Pet Food, Fragrance; Taste, Nutrition & Health +1.7%, Scent & Care -3.4%. ONE SYM driving cost savings and reinvestment; APAC & Americas up, EMEA down
29 April 2026
Neste Q1 2026 Interim Report
Strong Q1: comparable EBITDA EUR 861m; cash flow before financing EUR 286m; renewable margin USD 856/t; oil refining margin USD 23.0/bbl; leverage 31.7%; volumes hit by maintenance
29 April 2026
Worley to deliver FEED for Dow Path2Zero cogeneration in Canada
FEED for cogeneration with post-combustion carbon capture; brownfield unit targeted by 2030 to support net-zero Scope 1/2 and expand low-carbon polyethylene output.
28 April 2026
Sinopec RIPP’s Sinoketol wins Gold at Geneva Invention Exhibition
New cyclohexanone route via cyclohexene esterification–hydrogenation: >99.95% single‑pass conversion, >8× equilibrium, −14% activation energy; waste −70%, CO₂ −38%; first commercial 2×200k t/yr unit
28 April 2026
GSK: FDA grants priority review and Breakthrough Therapy for bepirovirsen
Phase III B-Well trials showed significantly higher functional cure rates and acceptable safety in chronic hepatitis B; drug is an antisense oligonucleotide; PDUFA date 26 Oct 2026
28 April 2026
UPM joint venture with Sappi enters EU Phase II merger review
EC opened Phase II on 28 Apr 2026. The proposed graphic-paper JV needs approvals in other jurisdictions; parties are cooperating and say the deal strengthens European supply resilience.
28 April 2026
BASF commissions world-scale menthol and linalool plants in Ludwigshafen and citral plant in Zhanjiang
Commercial production began April 2026; Ludwigshafen expansion leverages Verbund efficiencies, Zhanjiang citral boosts supply reliability and downstream feedstock; ~60 jobs.
28 April 2026
MAIRE's Nextchem awarded NX CONSER C5+ license and process design for TMA plant in China
Licensed process design and technical services for a continuous Trimellitic Anhydride (TMA) plant in China, cuts power, steam and water use; two-phase rollout, optional proprietary equipment.
28 April 2026
Novo Nordisk to present Wegovy and next‑generation obesity data at ECO 2026
Presenting 52 abstracts at ECO: data on semaglutide (injectable and oral), higher‑dose 7.2 mg, CagriSema combo, menopause effects, CV risk, weight‑loss timelines and real‑world outcomes.
28 April 2026
Evonik opens Asia PAthletic Center for sports polyamide innovation
Offers R&D, ISO/ASTM testing, pilot processing, 3D samples and application support for long‑chain polyamides (PEBAs) to accelerate sports and consumer product commercialization
28 April 2026
LKAB’s Malmberget sorting plant to secure future production
New sorting plant due 2028 replaces 1950s facility; capacity 24 Mt magnetite + 1 Mt hematite/yr; modern crushing, screening and magnetic separation; 27,000 m², peak 350 workers.
28 April 2026
Elkem wins NOK 87m from Enova to scale biocarbon use in silicon production
Project (total NOK242m, 2026–28) will test industrial biocarbon across labs, pilots and five smelters to double biocarbon share (from ~25%) by 2030, potentially cutting up to 0.5 Mt CO2/yr
28 April 2026
REMONDIS: Closing the Textile Loop
Joint initiatives improve textile collection, sorting and recycling; mechanical and chemical recycling needed for mixed fibres. EPR funding and eco-modulation to fund infrastructure and boost reuse.
28 April 2026
Air Liquide Q1 2026: growth and record investments
Q1 sales €6.8B (+3.4% ex-currency/energy). Gas & Services +2%; Healthcare +4%. Efficiencies €142M; operating cash flow +7%. Investments €1.5B, backlog €5.5B; DIG Airgas closed; +100bps margin target 2026.
28 April 2026
Boehringer Ingelheim’s survodutide achieves 16.6% weight loss in Phase III obesity trial
Trial met co-primary endpoints; 85.1% achieved ≥5% weight loss vs 38.8% placebo; weight loss mainly fat with reduced waist circumference; GI events were mild–moderate; MASH trials ongoing
28 April 2026
MAIRE’s Nextchem wins TMA licensing, process design and technical services contract in China with NX CONSER C5+
Continuous TMA production tech delivers power, steam and water savings. TMA feeds PVC plasticizers, coatings and polyester resins. Project in two phases with optional proprietary equipment supply.
28 April 2026
Sinopec's 12 Innovation Studios Join Petrochemical Industry Innovation Alliance
Company held an alliance exchange; emphasizes employee innovation studios - issued guidance, runs reviews; has 31 national and 182 group-level studios and will transfer innovations into production.
28 April 2026
Sinopec Deploys DeepSeek‑V4 Privately
DeepSeek‑V4 preview (1.6T params) was open‑sourced. The Flash model rivals top closed‑source systems in reasoning, is tuned for domestic chips, and was integrated into the group's AI platform.
27 April 2026
GSK efimosfermin granted FDA Breakthrough and EMA PRIME for MASH
Phase II data: once-monthly long-acting FGF21 candidate improved fibrosis and disease resolution in F2/F3, well tolerated; phase III underway and F4 trials planned; condition drives liver transplants
27 April 2026
Johnson Matthey chosen by Liquid Sunshine for Guangxi biomethanol plant
Planned biomethanol plant will use biomass gasification to produce 75,000 t/yr in phase 1; phase 2 could convert CO2 + electrolytic H2 to e‑methanol for e‑fuels, aiding marine decarbonisation.
27 April 2026
Johnson & Johnson’s IMAAVY granted FDA Priority Review for wAIHA
FDA granted Priority Review to nipocalimab sBLA for warm autoimmune hemolytic anemia after Phase 2/3 ENERGY showed durable hemoglobin responses and fatigue improvement; review ~6 months.
27 April 2026
Johnson & Johnson: FDA approves CAPLYTA sNDA to reduce schizophrenia relapse risk
FDA approved sNDA for CAPLYTA (lumateperone) to prevent relapse in schizophrenia. Phase 3 randomized‑withdrawal: 63% lower relapse risk (HR 0.37); 84% relapse‑free at 6 months; safety consistent.
27 April 2026
Lilly to acquire Ajax Therapeutics for AJ1‑11095, a first‑in‑class Type II JAK2 inhibitor
Lead program in Phase 1; POC data due late 2026. Designed to deliver deeper, more durable responses than current Type I JAK2 therapies. Deal may pay up to $2.3B, subject to closing.
27 April 2026
Evonik and Higuchi open joint lab in Yokohama
New Yokohama lab gives local formulators hands-on access to EUDRAGIT polymers, formulation support and technical services to speed oral drug development and boost regional innovation.
← Previous
Next →
